pyrimidine dimers has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunborg, G; Butt, ST; Christensen, T; Duale, N; Olsen, AK | 1 |
| El-Deiry, WS; Mori, T; Navaraj, A | 1 |
2 other study(ies) available for pyrimidine dimers and Breast Neoplasms
| Article | Year |
|---|---|
Octyl methoxycinnamate modulates gene expression and prevents cyclobutane pyrimidine dimer formation but not oxidative DNA damage in UV-exposed human cell lines.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cinnamates; DNA Damage; DNA, Neoplasm; Female; Fibroblasts; Gene Expression Regulation; Humans; Oxidative Stress; Pyrimidine Dimers; Sunscreening Agents; Ultraviolet Rays | 2010 |
Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers.
Topics: BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Survival; DNA Damage; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Radiation; Gene Expression Regulation, Neoplastic; Humans; Osteosarcoma; Pyrimidine Dimers; Time Factors; Tumor Suppressor Protein p53; Ultraviolet Rays; Xeroderma Pigmentosum | 2005 |